Last reviewed · How we verify
AdCh3NSmut; Ad6NSmut
AdCh3NSmut; Ad6NSmut is a Biologic drug developed by ReiThera Srl. It is currently in Phase 1 development.
At a glance
| Generic name | AdCh3NSmut; Ad6NSmut |
|---|---|
| Sponsor | ReiThera Srl |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of a Novel Therapeutic Vaccine for Hepatitis C Virus (PHASE1)
- A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AdCh3NSmut; Ad6NSmut CI brief — competitive landscape report
- AdCh3NSmut; Ad6NSmut updates RSS · CI watch RSS
- ReiThera Srl portfolio CI
Frequently asked questions about AdCh3NSmut; Ad6NSmut
What is AdCh3NSmut; Ad6NSmut?
AdCh3NSmut; Ad6NSmut is a Biologic drug developed by ReiThera Srl.
Who makes AdCh3NSmut; Ad6NSmut?
AdCh3NSmut; Ad6NSmut is developed by ReiThera Srl (see full ReiThera Srl pipeline at /company/reithera-srl).
What development phase is AdCh3NSmut; Ad6NSmut in?
AdCh3NSmut; Ad6NSmut is in Phase 1.
Related
- Manufacturer: ReiThera Srl — full pipeline